FOEHR MATTHEW W

Average Profitability
25.1%
Insider Buys Quantity
19
Insider Buys Sum
$6.8M
Insider Sells Quantity
14
Insider Sells Sum
$13.43M

Insider Activity of FOEHR MATTHEW W

According to the SEC Form 4 filings, FOEHR MATTHEW W, being in a position of

  1. President and CEO at OmniAb, Inc.,
    оver the last 12 months, has bought 760000 shares for $3.64M, and sold 0 shares,
    over all time since 2023-05-12, has bought 1360000 shares for $5.91M, and sold 0 shares.

The largest purchase of all time was on 2023-05-12 and amounted to 440000 shares of OmniAb, Inc. for $1.5M.

The largest sale of all time was on 2018-10-01 and amounted to 12000 shares of Ligand Pharmaceuticals Incorporated for $3.29M.

Biography of FOEHR MATTHEW W

No biography is available at this moment.

2024-05-24PurchaseOmniAb, Inc.
OABI
President and CEO
240,000
0.2109%
$4.42$1.06M-3.87%
2024-03-22PurchaseOmniAb, Inc.
OABI
President and CEO
225,000
0.1948%
$5.19$1.17M-14.06%
2023-12-12PurchaseOmniAb, Inc.
OABI
Chief Executive Officer
200,000
0.1722%
$5.05$1.01M-7.34%
2023-11-10PurchaseOmniAb, Inc.
OABI
President and CEO
95,000
0.0821%
$4.27$405,517+9.31%
2023-08-14PurchaseOmniAb, Inc.
OABI
President and CEO
45,000
0.0391%
$5.48$246,600-6.79%
2023-06-09PurchaseOmniAb, Inc.
OABI
Chief Executive Officer
115,000
0.1157%
$4.52$519,800+14.35%
2023-05-12PurchaseOmniAb, Inc.
OABI
Chief Executive Officer
440,000
0.4311%
$3.40$1.5M+48%
2022-05-13PurchaseLigand Pharmaceuticals Incorporated
LGND
President and COO
2,500
0.0143%
$82.76$206,910+21.81%
2022-05-02PurchaseViking Therapeutics, Inc.
VKTX
90,000
0.1144%
$2.47$222,390+53.75%
2021-06-10PurchaseViking Therapeutics, Inc.
VKTX
director
40,000
0.052%
$5.69$227,600-11.57%
2020-06-30SaleViking Therapeutics, Inc.
VKTX
director
26,000
0.0365%
$7.35$191,100-12.83%
2018-10-01SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
12,000
0.0573%
$273.88$3.29M-56.27%
2018-09-04SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
12,000
0.056%
$255.01$3.06M-52.36%
2018-05-10SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
8,881
0.0409%
$167.63$1.49M-5.11%
2018-02-23SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
5,444
0.0255%
$152.98$832,824+11.33%
2017-08-09SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
6,100
0.0023%
$9.97$60,817+21.97%
2017-05-12SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
5,621
0.0024%
$9.97$56,041+22.53%
2017-03-02SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
6,879
0.0032%
$9.97$68,584+26.14%
2016-11-15PurchaseViking Therapeutics, Inc.
VKTX
director
26,000
0.1333%
$1.21$31,356+6.78%
2016-08-05SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
12,500
0.0048%
$9.97$124,625-13.34%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.